In-house legal teams develop new attitude to risk
In the early stages of the Covid-19 pandemic, Pfizer chief executive Albert Bourla asked his managers: “If not us, then who?” The question gave the US pharma group a sense of urgency in the development of a coronavirus vaccine. Speed was crucial, so Pfizer had to change how it worked. In partnership with vaccine maker…
Read more